Ranolazine is used as a second-line agent in patients unable to tolerate first-line antianginal agents due to side effects or as a combination therapy with first-line agents in patients with residual angina. Iv
Giles TD, Pina IL, Quiroz AC et al (1992) Hemodynamic and neurohormonal responses to intravenous Nicorandil in congestive heart failure in humans. J Cardiovasc Pharmacol 20:572–578. doi:10.1097/00005344-199210000-00010 Article PubMed CAS Google Scholar Publication Committee for the VMAC [Vasod...
The use of nonsteroidal anti-inflammatory medications (NSAIDs), beta-blockers, chemotherapeutic agents, and the compound nicorandil have all been suggested as being risk factors for canker sore outbreaks. A biological explanation for this phenomenon. ...